Arnaud Le Goff
Overview
Explore the profile of Arnaud Le Goff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jarry U, Bostoen M, Pineau R, Chaillot L, Mennessier V, Montagne P, et al.
BMC Cancer
. 2021 May;
21(1):574.
PMID: 34011294
No abstract available.
2.
Jarry U, Bostoen M, Pineau R, Chaillot L, Mennessier V, Montagne P, et al.
BMC Cancer
. 2021 May;
21(1):530.
PMID: 33971844
Background: Osimertinib is a third generation tyrosine kinase inhibitor (TKI) that targets the epidermal growth factor receptor (EGFR) in lung cancer. However, although this molecule is not subject to some...
3.
Truchot M, Balanca B, Wey P, Tazarourte K, Lecomte F, Le Goff A, et al.
Mil Med
. 2020 Feb;
185(7-8):e1077-e1082.
PMID: 32091610
Introduction: The French army has implemented an algorithm based on the acronym "MARCHE RYAN," each letter standing for a key action to complete in order to help first care providers...
4.
Swiech A, de Rocquigny G, Martinez T, Loarer G, Vico S, Planchon J, et al.
Anaesth Crit Care Pain Med
. 2019 Oct;
39(1):59-64.
PMID: 31614243
Introduction: The current terrorist threat challenges nations to train numerous non-trauma care providers with different backgrounds in damage control (DC) strategies. The purpose of this work was to propose a...
5.
Ulve R, Rault M, Bahin M, Lagoutte L, Abadie J, de Brito C, et al.
Cancer Res
. 2017 Sep;
77(21):5721-5727.
PMID: 28883003
Canine cancers represent a tremendous natural resource due to their incidence and striking similarities to human cancers, sharing similar clinical and pathologic features as well as oncogenic events, including identical...
6.
Brocqueville G, Ndour P, Ouk T, Le Goff A, De Witte C, Mougel A, et al.
PLoS One
. 2013 May;
8(4):e60743.
PMID: 23637765
Background And Objectives: Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) is linked to a variety of malignancies including Hodgkin's disease, lymphomas, nasopharyngeal and gastric carcinoma. LMP1 exerts its transforming...
7.
Le Goff A, Ji Z, Leclercq B, Bourette R, Mougel A, Guerardel C, et al.
J Biol Chem
. 2012 Aug;
287(42):35382-35396.
PMID: 22915589
The GRB2-associated binder 1 (GAB1) docking/scaffold protein is a key mediator of the MET-tyrosine kinase receptor activated by hepatocyte growth factor/scatter factor (HGF/SF). Activated MET promotes recruitment and tyrosine phosphorylation...
8.
Goormachtigh G, Ji Z, Le Goff A, Fafeur V
Biochem Biophys Res Commun
. 2011 Jul;
411(4):780-5.
PMID: 21782801
The GRB2 associated binder 1 (GAB1) is an essential docking/adaptor protein for transmitting intracellular signals of the MET tyrosine kinase receptor activated by hepatocyte growth factor/scatter factor (HGF/SF). We found...